| Name | Title | Contact Details |
|---|---|---|
Michael Torres |
Vice President and General Counsel, Americas | Profile |
leadershipinmedicine is a Norwich, VT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Implant Sciences is the leader in next generation Explosives Trace Detection (ETD) technology. In January 2013, the Company became only the third ETD manufacturer, and the sole American-owned company, to have product approval from the US Transportation Security Administration. Implant Sciences has developed proprietary technologies used in its commercial explosives and drugs trace detection systems, which ship to a growing number of locations domestically and internationally. Implant Sciences' QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation and, in addition to receiving TSA qualification for air cargo screening, the Company's QS-B220 has also received STAC certification, a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act), and the GSN 2013 Homeland Security Award for "Best Explosives Detection Solution".
Arterys Inc. opens medical imaging to the power of the cloud. Arterys developed 4D Flow technology, which generates precise measurements of blood flow noninvasively and non-radiatively anywhere in the body.
Montvale Technologies is a Montvale, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Emrn Inc is a Le Gardeur, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.